[1]杜雪洋,梁建庆,何建成,等.黄芪多糖的药理作用研究[J].西部中医药,2019,32(06):152-155.
　DU Xueyang,LIANG Jianqing,HE Jiancheng,et al.Research Progress of Pharmacological Action of Astragalus Polysaccharides[J].Western Journal of Traditional Chinese Medicine,2019,32(06):152-155.
点击复制

黄芪多糖的药理作用研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年06期
页码:
152-155
栏目:
出版日期:
2019-06-15

文章信息/Info

Title:
Research Progress of Pharmacological Action of Astragalus Polysaccharides
文章编号:
1004-6852(2018)06-0152-04
作者:
杜雪洋1，梁建庆2,3' target="_blank" rel="external">3,4' target="_blank" rel="external">4,何建成5，李金田1,3' target="_blank" rel="external">3,4' target="_blank" rel="external">4，曾启宇1，胡蓉1，刘凤艳6，安耀荣2，贾育新2，吴玉泓2，刘香玉2，余焕钦2
1 甘肃中医药大学中医临床学院，甘肃 兰州 730000； 2 甘肃中医药大学基础医学院；3 敦煌医学与转化省部共建教育部重点实验室； 4 甘肃中医药大学博士后流动站； 5 上海中医药大学基础医学院； 6 甘肃中医药大学附属医院
Author(s):
DU Xueyang1, LIANG Jianqing2,3' target="_blank" rel="external">3,4' target="_blank" rel="external">4, HE Jiancheng5, LI Jintian1,3' target="_blank" rel="external">3,4' target="_blank" rel="external">4, ZENG Qiyu1, HU Rong1, LIU Fengyan6, AN Yaorong2, JIA Yuxin2, WU Yuhong2, LIU Xiangyu2, YU Huanqin2
1 TCM Clinical College, Gansu University of Chinese Medicine, Lanzhou 730000, China;2 Basic Medical College, Gansu University of Chinese Medicine; 3 Key Laboratory for Transfer of Dunhuang Medicine at the Provincial and Ministerial Level; 4 Postdoctoral Research Station, Gansu University of Chinese Medicine; 5 Basic Medical College, Shanghai University of TCM6 Affiliated Hospital of Gansu University of Chinese Medicine
关键词:
黄芪多糖; 药理作用; 研究述评
Keywords:
astragalus polysaccharide;  pharmacological action;  review
分类号:
R285
文献标志码:
A
摘要:
黄芪多糖作为中药黄芪的主要活性成分，关于其药理作用的研究多涉及循环系统、神经系统、消化系统、免疫系统、内分泌系统、造血系统，对近年来黄芪多糖在抗动脉粥样硬化，保护视网膜，改善记忆力、认知功能、抗衰老、抗骨质疏松及防治帕金森病等方面的药理作用进行归纳，为今后研究提供参考。
Abstract:
Astragalus polysaccharides is the main active ingredient of Huangqi (astragali radix), the studies on its pharmacological action involve circulatory system, nervous system, digestive system, immune system, endocrine system and hematopoietic system. The paper is mainly reviewing its pharmacological actions including anti-atherosclerosis, protecting retina, improving memory, cognitive function, anti-aging, anti-osteoporosis, preventing and treating Parkinson′s disease in the recent years, to provide the reference for future study.

相似文献/References:

[1]杨莹莹,张广晶,张舒媛,等.长春花药理作用研究进展[J].西部中医药,2014,27(10):170.
[2]陈耀章.玉米须化学成分药理作用最新研究[J].西部中医药,2015,28(02):141.
[3]李万军,马新焕,王建良.半夏的药理作用[J].西部中医药,2012,25(09):129.
　LI Wan-jun,MA Xin-huan,WANG Jian-liang.Pharmacological Action of BanXia[J].Western Journal of Traditional Chinese Medicine,2012,25(06):129.
[4]马博,张媛,张达义,等.杜仲的化学成分及其药理作用研究进展[J].西部中医药,2013,26(12):153.
　MA Bo,ZHANG Yuan,ZHANG Dayi,et al.Advance at Chemical Ingredients and Pharmacological Activity of DuZhong[J].Western Journal of Traditional Chinese Medicine,2013,26(06):153.
[5]苏韫,刘永琦,颜春鲁,等.黄芪多糖对脑缺血再灌注大鼠脑组织Bcl-2、Bax蛋白及NO含量的影响[J].西部中医药,2016,29(03):10.
　SU Yun,LIU Yongqi,YAN Chunlu,et al.Influence of Astragalus Polysaccharides on the Contents of Bcl-2, Bax Protein and NO in the Brain Tissue of the Rats with Cerebral Ischemia Reperfusion[J].Western Journal of Traditional Chinese Medicine,2016,29(06):10.
[6]刘如秀,刘宇,汪艳丽,等.当归的药理作用[J].西部中医药,2014,27(11):153.
[7]杜慧,徐凡翔△.独一味现代药理作用机制研究进展*[J].西部中医药,2014,27(12):135.
[8]相萍萍,王旭,刘超△.铁皮石斛的最新应用研究[J].西部中医药,2016,29(01):129.
　XIANG Pingping,WANG Xu,LIU Chao.The Latest Study on TiePi ShiHu[J].Western Journal of Traditional Chinese Medicine,2016,29(06):129.
[9]乔莉,郑慧,杨丽霞,等.基于CNKI数据挖掘分析黄芪多糖治疗糖尿病的文献特征和研究现状[J].西部中医药,2017,30(03):56.
　QIAO Li,ZHENG Hui,YANG Lixia,et al.Analysis of Literature Characteristics and Research Status of Astragalus Polysaccharides in Treating Diabetes Based on CNKI Data Mining[J].Western Journal of Traditional Chinese Medicine,2017,30(06):56.
[10]王炯,陈涵,王章东,等.红豆杉的药理作用及毒性小考[J].西部中医药,2017,30(04):139.
　WANG Jiong,CHEN Han,WANG Zhangdong,et al.Study on the Toxicity and Pharmacological Action of Chinese Yew[J].Western Journal of Traditional Chinese Medicine,2017,30(06):139.

备注/Memo

备注/Memo:
收稿日期：2018-11-01*基金项目：国家自然科学基金（编号81573899，81660767），甘肃中医药大学中青年科研基金（编号ZQ2015-17），敦煌医学与转化省部共建教育部重点实验室开放课题（编号DHYX1516-08）；甘肃中医药大学研究生创新基金项目(编号CX2018-01)。作者简介：杜雪洋(1991—)，女，在读硕士研究生。研究方向：中药治疗辐射损伤的研究。△通讯作者：梁建庆(1976—)，男，博士学位，副教授。研究方向：中药治疗帕金森病的研究。
更新日期/Last Update: 2019-06-15